Fake drugs are dangerous and pose a major public threat to the health. Blue Sphere Health Ltd (Bluesphere) has been working with global drug companies to enable their drugs to be more easily tracked and authenticated. This year has seen a major growth in demand from drug companies including three major customers with some household name brands. Bluesphere, based in Cambridge U.K., has expansion plans for 2015.
As Bluesphere CEO Mark Davison comments "After a few years where "serialization" (pack coding) has taken centre stage, driven by impending legislation in the EU, USA and elsewhere, we are seeing a renewed focus on the need to authenticate the product by other means too. Codes can be copied so traceability is only one part of the solution. We are seeing a large increase in demand for a more balanced brand protection strategy"
Bluesphere works with customers to develop and implement an integrated approach for maintaining product integrity which focuses on three key areas: physical security such as hard-to-copy pack features, digital security such as using codes to make drugs traceable, and process security such as improving how supply chains work to eliminate opportunities for theft, diversion and fraud.
There are many must-do activities in relation to new legal requirements such as the EU Falsified Medicines Directive, the Drug Quality and Security Act in the USA, and various regulatory initiatives elsewhere. To make sure that these compliance-driven projects form part of a well-thought-out strategy, Bluesphere provides analysis, strategy development and tactical support services. The relatively small investment in upfront consultancy usually more than pays off in efficiency savings during implementation. Bluesphere also supports governments, regulators and third sector (NGO) customers who need to protect the public from counterfeit and sub-standard medicines.
For many drug companies the budgeting process for 2015 has started. Contact Bluesphere today to see how an investment in consultancy can help you keep your patients safe.
*******
Contact Mark Davison for a confidential discussion.
Email: [email protected]
Twitter: @StopFakeDrugs
LinkedIn: uk.linkedin.com/in/markdavison100
Book: "Pharmaceutical Anti-Counterfeiting: Combating the Real anger from Fake Drugs" Wiley, New York, 2011 (see Amazon.com for reviews)
___________________________________________________